Hong Kong extends recall to all UK-made Augmentin formulations
This article was originally published in Scrip
Executive Summary
Hong Kong's department of health has ordered GlaxoSmithKline to recall two additional formulations of Augmentin (amoxicillin clavulanate) following the discovery of plasticisers in the products.